Kymera Therapeutics, Inc.
$119.05
+0.24 (+0.20%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +18.7%
- 3 Months
- +67.0%
- YTD
- +53.0%
- 1 Year
- +189.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 63.8%
- Largest decline max drawdown, since Aug 2025
- -27.7%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.95
Own KYMR?
See how KYMR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.